Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The main objectives of the study were to assess the effects of fenofibrate on serum alkaline
phosphatase, as a composite endpoint and on safety in participants with primary biliary
cholangitis (PBC).